Seon-Wook Hwang
Algemeen Directeur bij NOVMETAPHARMA CO., LTD.
Vermogen: 17 M $ op 31-07-2023
Profiel
Seon-Wook Hwang is currently the President, Co-Chief Executive Officer & Director at NovMetaPharma Co., Ltd.
He is also the Chief Executive Officer at PNC Holdings Co. Ltd.
and NovMetaHealth Co. Ltd.
Mr. Hwang completed his undergraduate and graduate degrees at Chung-Ang University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVMETAPHARMA CO., LTD.
9.36% | 30-06-2023 | 1 038 030 ( 9.36% ) | 17 M $ | 31-07-2023 |
Actieve functies van Seon-Wook Hwang
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Algemeen Directeur | 04-11-2010 |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Algemeen Directeur | 01-03-2016 |
| PNC Holdings Co. Ltd. | Algemeen Directeur | 01-09-2015 |
Opleiding van Seon-Wook Hwang
| Chung-Ang University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| PNC Holdings Co. Ltd. | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
